To view this email as a web page, click here.

 
 
Lessons learned from a failed treatment for axial spondyloarthritis
A well-established treatment for psoriasis, psoriatic arthritis, and Crohn’s disease failed to work in axial spondyloarthritis patients, a study shows. But the study's failure may tell us more than not.
Read more
 
Less is More for TNFi Dosing in Axial Spondyloarthritis
Researchers writing in Arthritis Research and Therapy describe the results of a randomized clincal trial in which most patients with Ankylosing spondylitis maintained low disease activity or remission with standard or reduced TNFi dose schedules.
Read more
ADVERTISEMENT

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.